Lyfegen Raises CHF 5 Million Series A Funding to Expand Globally in Drug Rebate Management Lyfegen has successfully secured an additional CHF 5 million in Series A funding, enhancing its capabilities in drug rebate management technology for global markets.

Lyfegen Raises CHF 5 Million Series A Funding to Expand Globally in Drug Rebate Management #Switzerland #funding #Basel #Lyfegen #Drug_Rebate